Norfluoxetine Enantiomers as Inhibitors of Serotonin Uptake in Rat Brain

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Neuropsychopharmacology

• Publication date

  1993-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/npp.1993.33PMID 8512621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serotonin-selective antidepressants.

  2009cited by this paper
• Analysis of the Enantiomers of Fluoxetine and Norfluoxetine in Plasma and Tissue Using Chiral Derivatization and Normal-Phase Liquid Chromatography

  1992cited by this paper
• Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors.

  1991cited by this paper
• Fluoxetine, a selective inhibitor of serotonin uptake

  1991cited by this paper
• Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors.

  1990cited by this paper
• Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression.

  1990cited by this paper
• Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortex.

  1989cited by this paper
• Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor.

  1988cited by this paper
• Characterization of [3H]Paroxetine Binding in Rat Brain

  1988cited by this paper
• Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.

  1985cited by this paper
• Inhibition of serotonin uptake by optical isomers of fluoxetine

  1985cited by this paper
• Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.

  1983cited by this paper
• The new generation of antidepressants.

  1983cited by this paper
• Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.

  1983cited by this paper
• The new generation of antidepressants.

  1983cited by this paper
• AMINE UPTAKE INHIBITORS: CRITERIA OF SELECTIVITY

  1980cited by this paper
• (1S,3R,4S)-1-Methyl-3-(4-methoxyphenoxymethyl)-4-phenylpiperidinium chloride (FG4963): a selective inhibitor of serotonin uptake

  1979cited by this paper
• Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-comparison of fluoxetine and chlorimipramine.

  1978cited by this paper
• Fluoxetine, a selective serotonin uptake inhibitor

  1978cited by this paper
• The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.

  1976cited by this paper
• Effects of serotonin uptake inhibitor, Lilly 110140, on transport of serotonin in rat and human blood platelets.

  1976cited by this paper
• The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.

  1976cited by this paper
• A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.

  1975cited by this paper
• A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine.

  1974cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Ecotoxicological implications of increased antidepressant concentrations in the Laurentian Great Lakes Basin, 2018-2023.

  2025cites this paper
• Fluoxetine promotes IL-10–dependent metabolic defenses to protect from sepsis-induced lethality

  2025cites this paper
• Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy

  2025influential citation
• From Prescription to Pollution: Assessing the Ecological Impact and Treatment Technologies for Antidepressant Contaminants

  2025cites this paper
• Development of a Predictive Model for N-Dealkylation of Amine Contaminants Based on Machine Learning Methods

  2024cites this paper
• Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters

  2023cites this paper
• Spontaneous Resolution of RS-Fluoxetine to a Racemic Conglomerate upon Salt Formation with Oxalic Acid

  2022cites this paper
• Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19

  2022cites this paper
• Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants

  2021cites this paper
• The potential for adverse effects in fish exposed to antidepressants in the aquatic environment.

  2021cites this paper
• Potential Role of Adult Hippocampal Neurogenesis in Traumatic Brain Injury.

  2021cites this paper
• The Metabolic Rainbow: Deep Learning Phase I Metabolism in Five Colors

  2020cites this paper
• Do environmentally relevant concentrations of fluoxetine and citalopram impair stress-related behavior in zebrafish (Danio rerio) embryos?

  2020cites this paper
• Ultrasound-assisted dispersive liquid–liquid microextraction coupled with field-amplified capillary electrophoresis for sensitive and quantitative determination of fluoxetine and norfluoxetine enantiomers in biological fluids

  2020cites this paper
• Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice

  2019cites this paper
• Preconcentration and Determination Of Fluoxetine and Norfluoxetine in Biological and Water Samples with β-cyclodextrin Multi-walled Carbon Nanotubes as a Suitable Hollow Fiber Solid phase Microextraction Sorbent and High Performance Liquid Chromatography

  2019cites this paper
• Selective Serotonin Reuptake Inhibitor Use and Risk of Gastrointestinal and Intracranial Bleeding

  2019cites this paper
• Investigation into the molecular mechanisms of the norepinephrine and serotonin transporters in Attention Deficit/Hyperactivity Disorder

  2018cites this paper
• Computationally Assessing the Bioactivation of Drugs by N-Dealkylation.

  2018cites this paper
• Applicability evaluation of advanced processes for elimination of neurophysiological activity of antidepressant fluoxetine.

  2018cites this paper
• Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET

  2017cites this paper
• Molecular Imaging in Adult Attention Deficit / Hyperactivity Disorder

  2016cites this paper
• Simultaneous enantioselective quantification of fluoxetine and norfluoxetine in human milk by direct sample injection using 2-dimensional liquid chromatography-tandem mass spectrometry.

  2016cites this paper
• Simultaneous extraction and determination of trace amounts of olanzapine and fluoxetine from biological fluids: comparison of conventional hollow fiber supported liquid phase microextraction and pulsed electrically assisted liquid-phase microextraction techniques

  2015cites this paper
• Fluoxetine: a case history of its discovery and preclinical development

  2014cites this paper
• Mini FocuS iSSue : tieRed appRoach to BioanalySiS

  2014cites this paper
• Acute hemodynamic effects of a selective serotonin reuptake inhibitor in postural tachycardia syndrome: A randomized, crossover trial

  2014cites this paper
• Bioanalysis of chiral compounds during drug development using a tiered approach.

  2014cites this paper
• Enantioselective reduction of propiophenone formed from 3-chloropropiophenone and stereoinversion of the resulting alcohols in selected yeast cultures

  2014cites this paper
• Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study

  2014cites this paper
• Population PK modelling and simulation based on fluoxetine and norfluoxetine concentrations in milk: a milk concentration-based prediction model.

  2014cites this paper
• Chronic fluoxetine reduces autonomic control of cardiac rhythms in rats with congestive heart failure.

  2013cites this paper
• Enantiomer-specific in vitro biotransformation of select pharmaceuticals in rainbow trout (Oncorhynchus mykiss).

  2013cites this paper
• DESNUTRIÇÃO PREGRESSA E/OU MANIPULAÇÃO FARMACOLÓGICA DO SISTEMA SEROTONINÉRGICO: ESTUDO COMPORTAMENTAL E DA RESPOSTA IMUNE

  2012cites this paper
• The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.

  2012cites this paper
• Trace analysis of fluoxetine and its metabolite norfluoxetine. Part II: Enantioselective quantification and studies of matrix effects in raw and treated wastewater by solid phase extraction and liquid chromatography-tandem mass spectrometry.

  2012cites this paper
• Pharmacogenetics of drug-induced birth defects: what is known so far?

  2011cites this paper
• Active Pharmaceutical Ingredients andAquatic Organisms

  2011cites this paper
• The effects of fluoxetine exposure on growth and metabolism in the goldfish, Carassius auratus

  2010cites this paper
• SIMPLE DETERMINATION OF FLUOXETINE AND NORFLUOXETINE IN HUMAN SERUM AND URINE BY DABSYLATION FOLLOWED BY HPLC WITH VISIBLE LIGHT DETECTION

  2010influential citation
• In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis

  2010cites this paper
• Pharmacologically active metabolites of currently marketed drugs: potential resources for new drug discovery and development.

  2010cites this paper
• Disposition of Chiral and Racemic Fluoxetine and Norfluoxetine Across Childbearing

  2010cites this paper
• DETERMINATION OF FLUOXETINE ENANTIOMERS IN HUMAN SERUM AND URINE BY ISOCRATIC HPLC AND PRE-COLUMN FLUORESCENCE DERIVATIZATION WITH (R)-(+)-4-NITRO-7-(2-CHLOROFORMYLPYRROLIDIN-1-YL)-2,1,3-BENZOXADIAZOLE

  2010influential citation
• Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma.

  2010cites this paper
• Enantioselective Analysis of Fluoxetine and Norfluoxetine by LC in Culture Medium for Application in Biotransformation Studies Employing Fungi

  2009cites this paper
• Mechanisms by which the serotonergic system inhibits micturition in rats.

  2009cites this paper
• Determination of Fluoxetine and Norfluoxetine in Human Serum and Urine by HPLC Using a Cholester Column with Fluorescence Detection

  2009influential citation
• Determination of fluoxetine and norfluoxetine enantiomers in human plasma by polypyrrole-coated capillary in-tube solid-phase microextraction coupled with liquid chromatography-fluorescence detection.

  2009cites this paper
• A new, non-SSRI mechanism of action for Prozac.

  2007cites this paper
• Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate.

  2007cites this paper
• GABAA receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: Possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders

  2007cites this paper
• GABA(A) receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders.

  2007cites this paper
• The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants

  2006cites this paper
• Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake

  2006cites this paper
• The Complexity of Active Metabolites in Therapeutic Drug Monitoring of Psychotropic Drugs

  2006cites this paper
• Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.

  2005cites this paper
• Clinical Pharmacology of New Classes of Antidepressant Drugs

  2005cites this paper
• Escitalopram versus citalopram: the surprising role of the R-enantiomer

  2004cites this paper
• Malnutrition during brain growth spurt alters the effect of fluoxetine on aggressive behavior in adult rats.

  2004cites this paper
• Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids.

  2004cites this paper
• Stereoselectivity in Drug Action and Disposition: An Overview

  2004cites this paper
• and Disposition: An Overview

  2004cites this paper
• Stereoselective pharmacokinetics and placental transfer of fluoxetine and norfluoxetine in pregnant sheep under steady-state conditions

  2004cites this paper
• and Pharmacodynamics: Selected Classes of Drugs

  2004cites this paper
• Stereospecific Pharmacokinetics and Pharmacodynamics: Selected Classes of Drugs

  2004cites this paper
• Stereoisomerism(Chirality) of Psychotropic Drugs

  2003cites this paper
• Effects of fluoxetine and d-fenfluramine on cocaine-seeking behavior in rats

  2003cites this paper
• In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine

  2003cites this paper
• Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats.

  2003cites this paper
• The American Academy of Veterinary Pharmacology and Therapeutics Proceedings of the Thirteenth Biennial Symposium

  2003cites this paper
• The American Academy of Veterinary Pharmacology and Therapeutics Proceedings of the Thirteenth Biennial Symposium

  2003cites this paper
• Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

  2002cites this paper
• The importance of stereoselective determination of drugs in the clinical laboratory.

  2002cites this paper
• R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus: An in vivo Microdialysis and Receptor Binding Study

  2002influential citation
• Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?

  2002cites this paper
• Plasma Concentrations of the Enantiomers of Fluoxetine and Norfluoxetine: Sources of Variability and Preliminary Observations on Relations With Clinical Response

  2002cites this paper
• Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.

  2002cites this paper
• Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.

  2002cites this paper
• Effect of Alosetron on the Pharmacokinetics of Fluoxetine

  2001cites this paper
• Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy.

  2001cites this paper
• The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain

  2001cites this paper
• CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages

  2001cites this paper
• Concentrations of the Enantiomers of Fluoxetine and Norfluoxetine After Multiple Doses of Fluoxetine in Cytochrome P4502D6 Poor and Extensive Metabolizers

  2001cites this paper
• Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors.

  2000cites this paper
• Depression therapy: Future prospects

  2000cites this paper
• Pharmacokinetics and pharmacodynamics of the selective serotonin reuptake inhibitors, fluoxetine and paroxetine, during pregnancy and the nursing period

  2000cites this paper
• Monoamine oxidase a inhibition by fluoxetine: An in vitro and in vivo study

  1999cites this paper
• Chirality and Drugs Used in Psychiatry: Nice to Know or Need to Know?

  1999cites this paper
• Differential effects of fluoxetine and citalopram treatments on serotonin 5-HT(2C) receptor occupancy in rat brain.

  1999cites this paper
• The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine.

  1999cites this paper
• Psychopharmacology of Depression in the Next Millennium

  1999cites this paper
• Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology

  1998cites this paper
• Evaluation of the binding of the radiolabeled antidepressant drug, 18F-fluoxetine in the rodent brain: an in vitro and in vivo study.

  1998cites this paper
• Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants.

  1998cites this paper
• Metabolism of the Newer Antidepressants

  1998cites this paper
• Care of depression in the elderly: comparative pharmacokinetics of SSRIs

  1998cites this paper
• S-Fluoxetine in the Prophylaxis of Migraine: A Phase II Double-Blind Randomized Placebo-Controlled Study

  1998cites this paper
• Neurochemical effects of the enantiomers of mirtazapine in normal rats.

  1998cites this paper
• The Role of Metabolites of Antidepressants in the Treatment of Depression

  1997cites this paper